Class IIOngoingD-0016-2027
Drug recall · October 14, 2026
IMAAVY (nipocalimab-aahu) Injection recall
Why: Presence of particulate matter.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01
- Lots / codes
Lot JNYJ1208; Exp. 10/30/2027
- Quantity
- 49 vials
- Company
- J&J Innovative Medicine, Malvern, PA
- Distribution
- OH
- Initiated
- September 23, 2026 · Voluntary: Firm initiated
- Classified
- October 8, 2026
- Reported
- October 14, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.